View source for Carcinoma in situ, any site

{{ICD10 transition status
| OldDxArticle =
| CurrentStatus = reconciled
| InitialEditorAssigned = Debbie Page-Newton
}}
{{ICD10 dx
| MinimumCombinedCodes =
| ICD10 Code=D09
| BugRequired= 
}}
{{ICD10 category|Neoplastic}} 

== Additional Info ==
Carcinoma in situ

*Carcinoma in situ (CIS), also known as in situ neoplasm, is a group of abnormal cells. While they are a form of neoplasm, there is disagreement over whether CIS should be classified as cancer. This controversy also depends on the exact CIS in question (i.e. cervical, skin, breast). Some authors do not classify them as cancer, however, recognizing that they can potentially become cancer. Others classify certain types as a non-invasive form of cancer. The term "pre-cancer" has also been used.

*These abnormal cells grow in their normal place, thus "in situ" (from Latin for "in its place"). For example, carcinoma in situ of the skin, also called Bowen's disease, is the accumulation of dysplastic epidermal cells within the epidermis only, that has failed to penetrate into the deeper dermis. For this reason, CIS will usually not form a tumor. Rather, the lesion is flat (in the skin, cervix, etc.) or follows the existing architecture of the organ (in the breast, lung, etc.). Exceptions include CIS of the colon (polyps), the bladder (preinvasive papillary cancer), or the breast (ductal carcinoma in situ or lobular carcinoma in situ).

*Many forms of CIS have a high probability of progression into cancer, and therefore removal may be recommended; however, progression of CIS is known to be highly variable and not all CIS becomes invasive cancer.

*In the TNM classification, carcinoma in situ is reported as TisN0M0 (stage 0).

== Alternate ICD10s to consider coding instead or in addition ==


== Candidate [[Combined ICD10 codes]] ==

== Related CCI Codes ==

== Related Articles ==
{{Related Articles}}

{{ICD10 footer}}
{{EndPlaceHolder}}